1018899-04-1 sotagliflozin sotagliflozin intermediate
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Our advantage of Sotagliflozin CAS 1018899-04-1:
1) high quality & high purity 99% up with competitive price
2) GMP certified facrtory
3) Quick delivery & provide free sample in 3 days after your payment
Product Description
Specification of Sotagliflozin CAS 1018899-04-1
Usage of Sotagliflozin CAS 1018899-04-1
Soglizin LX-4211 is a new oral diabetes drug developed by Sanofi and Lescon Pharmaceuticals. As a dual inhibitor of SGLT-1 and SGLT-2,
the drug can reduce postprandial blood glucose, increase GLP-1 and promote urinary glucose excretion.
Packaging & Shipping
1kg/tin, 5tin.ctn, or as your requirement
Company Information
CAS NO:33069-62-4
CAS NO:68890-66-4
CAS NO:69388-79-0
CAS NO:1492-18-8
CAS NO:23828-92-4
CAS NO:361442-04-8
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View